Related references
Note: Only part of the references are listed.Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases A Mendelian Randomization Study
Michael G. Levin et al.
JAMA NETWORK OPEN (2021)
Use of Latent Class Analysis and k-Means Clustering to Identify Complex Patient Profiles
Richard W. Grant et al.
JAMA NETWORK OPEN (2020)
The Missing Diversity in Human Genetic Studies
Giorgio Sirugo et al.
CELL (2019)
Artificial Intelligence in Cardiovascular Imaging JACC State-of-the-Art Review
Damini Dey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases
Ning Ding et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
PCSK9 inhibitors: clinical evidence and implementation
Marc S. Sabatine
NATURE REVIEWS CARDIOLOGY (2019)
Collider scope: when selection bias can substantially influence observed associations
Marcus R. Munafo et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients
Tariq Ahmad et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes A Multicenter Registry Study
Taku Inohara et al.
JAMA CARDIOLOGY (2018)
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
Amit V. Khera et al.
NATURE GENETICS (2018)
PCSK9 Inhibitors Economics and Policy
Mark A. Hlatky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes The Framingham Heart Study
Ravi V. Shah et al.
JAMA CARDIOLOGY (2017)
Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting
Pradeep Natarajan et al.
CIRCULATION (2017)
Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study
Robert M. Stoekenbroek et al.
EUROPEAN HEART JOURNAL (2016)
Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial)
Iftikhar J. Kullo et al.
CIRCULATION (2016)
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population
Jamal S. Rana et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Jacob H. Levine et al.
CELL (2015)
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
Jessica L. Mega et al.
LANCET (2015)
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson et al.
NATURE (2015)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
CIRCULATION (2014)
Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations
Paul Muntner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Clinical Implications of Chronic Heart Failure Phenotypes Defined by Cluster Analysis
Tariq Ahmad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Usefulness of the Addition of Beta-2-Microglobulin, Cystatin C and C-Reactive Protein to an Established Risk Factors Model to Improve Mortality Risk Prediction in Patients Undergoing Coronary Angiography
Kevin T. Nead et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Alternative Ankle-Brachial Index Method Identifies Additional At-Risk Individuals
Kevin T. Nead et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Genetic determinants of the ankle-brachial index: A meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium
Christina L. Wassel et al.
ATHEROSCLEROSIS (2012)
Association Between Chromosome 9p21 Variants and the Ankle-Brachial Index Identified by a Meta-Analysis of 21 Genome-Wide Association Studies
Joanne M. Murabito et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
Low lifetime recreational activity is a risk factor for peripheral arterial disease
Andrew M. Wilson et al.
JOURNAL OF VASCULAR SURGERY (2011)
Discriminant analysis of principal components: a new method for the analysis of genetically structured populations
Thibaut Jombart et al.
BMC GENETICS (2010)
The 9p21 Myocardial Infarction Risk Allele Increases Risk of Peripheral Artery Disease in Older People
Christie Cluett et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Clustering Algorithms: On Learning, Validation, Performance, and Applications to Genomics
Lori Dalton et al.
CURRENT GENOMICS (2009)
adegenet:: a R package for the multivariate analysis of genetic markers
Thibaut Jombart
BIOINFORMATICS (2008)
A common variant on chromosome 9p21 affects the risk of myocardial infarction
Anna Helgadottir et al.
SCIENCE (2007)
A common allele on chromosome 9 associated with coronary heart disease
Ruth McPherson et al.
SCIENCE (2007)
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Paul R. Burton et al.
NATURE (2007)
Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation
RB D'Agostino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
